INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 13, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,623 |
| Dec 18, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
| Dec 04, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
| Nov 03, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
| Feb 10, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Other acquisition or disposition | -- | -- | 5,676 |
| Dec 19, 2016 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,676 |
| Feb 08, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 5 | Other acquisition or disposition | -- | -- | 5,702 |
| Dec 20, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 4 | Other acquisition or disposition | -- | -- | 5,702 |
| Dec 13, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 4 | Other acquisition or disposition | -- | -- | 5,702 |
| Feb 11, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,720 | -- | 5,720 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.